Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation, HomologousTransplantation ConditioningMelphalanHematologic NeoplasmsStem Cell TransplantationGranulocyte Colony-Stimulating FactorCombined Modality TherapyLeukapheresisAntigens, CD34Blood Component RemovalMultiple MyelomaCyclophosphamideGraft vs Host DiseaseAntineoplastic Combined Chemotherapy ProtocolsBusulfanMyeloablative AgonistsStem CellsTreatment OutcomeHematopoietic Stem CellsGraft SurvivalBone Marrow TransplantationLymphoma, Non-HodgkinEtoposideThiotepaRemission InductionAntineoplastic Agents, AlkylatingRecurrenceCytophagocytosisCarmustineSalvage TherapyIfosfamideAmyloidosisTissue DonorsVincristineCord Blood Stem Cell TransplantationHematopoiesisHodgkin DiseaseRetrospective StudiesTransplantation ChimeraDisease-Free SurvivalCytarabineNeoplasmsSurvival RateWhole-Body IrradiationTime FactorsHistocompatibilitySurvival AnalysisHistocompatibility TestingInfectionImmunosuppressive AgentsCytomegalovirus InfectionsLymphoma, T-CellDoxorubicinPOEMS SyndromePlatelet CountLeukemia, Myeloid, AcuteLeukemiaPrednisoneVidarabineCarboplatinFollow-Up StudiesTransplantation, IsogeneicDexamethasoneFatal OutcomeAntineoplastic AgentsBone Marrow PurgingProspective StudiesBlood Cell CountRecombinant ProteinsGraft vs Leukemia EffectLymphomaOpportunistic InfectionsEmbryonic Stem CellsBlood CellsFeasibility StudiesAnemia, AplasticMyelodysplastic SyndromesMesenchymal Stem Cell TransplantationAdult Stem CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic DiseasesLymphocyte DepletionImmunophenotypingKidney TransplantationCyclosporinePrecursor Cell Lymphoblastic Leukemia-LymphomaT-LymphocytesHLA AntigensImmunosuppressionTransplantationBlood Transfusion, AutologousPrognosisLiver TransplantationBlood DonorsFlow CytometryCell Separation